SCHEMBL2621797

SCHEMBL2621797

CN1CCC(Oc2ccnc3ccc(Br)cc23)C1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.52
▸ HCRTR2 O43614 1/20 0.52
▸ PIK3CD O00329 3/20 0.46
▸ PIK3CA P42336 3/20 0.46
▸ PIK3CB P42338 3/20 0.46
▸ PIK3CG P48736 3/20 0.46
▸ HTT P42858 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ ERBB2 P04626 1/20 0.43
▸ EPHA2 P29317 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ EPHB4 P54760 1/20 0.43
▸ NCF1 P14598 1/20 0.42
▸ PDPK1 O15530 1/20 0.41
▸ KRAS P01116 1/20 0.41
▸ SOS1 Q07889 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2621800 0.94 HCRTR1 (0.50) HCRTR1HCRTR2PIK3CDPIK3CAPIK3CB
SCHEMBL22392626 0.84 HCRTR1 (0.51) HCRTR1HCRTR2NCF1
SCHEMBL19723307 0.83 EGFR (0.46) HCRTR1HCRTR2HTTMEN1POLB
SCHEMBL2621811 0.83 EGFR (0.46) HCRTR1HCRTR2HTTMEN1POLB
SCHEMBL2621812 0.83 EGFR (0.46) HCRTR1HCRTR2HTTMEN1POLB
SCHEMBL20074469 0.77 IDO1 (0.55) HCRTR1HCRTR2PIK3CDPIK3CAPIK3CB
SCHEMBL30880565 0.76 GAK (0.53) PIK3CDPIK3CAPIK3CBPIK3CGERBB2
SCHEMBL12850523 0.73 IRAK4 (0.65) PIK3CDPIK3CAPIK3CBPIK3CGHTT
SCHEMBL20292863 0.73 DYRK1A (0.58) HTTMEN1POLBKMT2ANCF1
SCHEMBL24714032 0.73 NOS3 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560967-B1 Heterocyclic carboxylic acid amides as PDK1 inihibitors BOEHRINGER INGELHEIM INT (DE) 2017-12-20 — — EP disclosed
US-8575203-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-11-05 — — US disclosed
US-8575203-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-11-05 — — US disclosed
US-20120094976-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 — — US disclosed
US-20120094976-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 — — US disclosed
WO-2011131741-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDES AS PDK1 INIHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094976-A1 NEW CHEMICAL COMPOUNDS CCNB1, MKI67, CCNA1 HCRTR1 1385/4885HCRTR2 2736/4885PIK3CD 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback